Colgate-Palmolive (CL) 8-K Colgate Announces 1st Quarter 2013 Results

EXHIBIT 99.2

Colgate-Palmolive Company

Segment Information (Reclassified)

(Dollars in Millions) (Unaudited)

	Three Months Ended
	June 30,		September 30,		December 31,
	2012		2012		2012
Net sales
Oral, Personal and Home Care
North America	$	727	$	766	$	754
Latin America	1,300		1,276		1,255
Europe/South Pacific	850		865		848
Greater Asia/Africa	859		897		870
Total Oral, Personal and Home Care	3,736		3,804		3,727
Pet Nutrition	531		528		559
Total Net sales	$	4,267	$	4,332	$	4,286

	Years ended December 31,
	2012		2011		2010		2009		2008
Net sales
Oral, Personal and Home Care
North America(1)	$	2,971	$	2,878	$	2,880	$	2,828	$	2,739
Latin America	5,032		4,895		4,386		4,441		4,201
Europe/South Pacific	3,417		3,508		3,220		3,271		3,582
Greater Asia/Africa	3,505		3,281		2,998		2,655		2,660
Total Oral, Personal and Home Care	14,925		14,562		13,484		13,195		13,182
Pet Nutrition(2)	2,160		2,172		2,080		2,132		2,148
Total Net sales	$	17,085	$	16,734	$	15,564	$	15,327	$	15,330

⁽¹⁾  Net sales in the U.S. for Oral, Personal and Home Care were $2,669, $2,567, $2,591, $2,577 and $2,490 in 2012, 2011, 2010, 2009 and 2008, respectively.

⁽²⁾  Net sales in the U.S. for Pet Nutrition were $1,052, $1,032, $1,025, $1,071 and $1,082 in 2012, 2011, 2010, 2009 and 2008, respectively.

EXHIBIT 99.2

Colgate-Palmolive Company

Segment Information (Reclassified)

(Dollars in Millions) (Unaudited)

	Three months ended
	June 30,			September 30,			December 31,
	2012			2012			2012
Operating profit
Oral, Personal and Home Care
North America	$	190		$	213		$	230
Latin America	373			377			354
Europe/South Pacific	179			198			187
Greater Asia/Africa	220			231			215
Total Oral, Personal and Home Care	962			1,019			986
Pet Nutrition	145			147			149
Corporate	(125		)	(139		)	(193		)
Total Operating profit	$	982		$	1,027		$	942

	Years ended December 31,
	2012			2011			2010			2009			2008
Operating profit
Oral, Personal and Home Care
North America	$	810		$	768		$	849		$	810		$	665
Latin America	1,454			1,437			1,330			1,393			1,205
Europe/South Pacific	747			715			742			748			746
Greater Asia/Africa	886			807			767			631			527
Total Oral, Personal and Home Care	3,897			3,727			3,688			3,582			3,143
Pet Nutrition	589			560			559			555			542
Corporate	(597		)	(446		)	(758		)	(522		)	(584		)
Total Operating profit	$	3,889		$	3,841		$	3,489		$	3,615		$	3,101

EXHIBIT 99.2

Colgate-Palmolive Company

Segment Information (Reclassified)

(Dollars in Millions) (Unaudited)

	Years ended December 31,
	2012		2011		2010		2009		2008
Capital expenditures
Oral, Personal and Home Care
North America	$	43	$	53	$	57	$	62	$	42
Latin America	237		195		138		105		112
Europe/South Pacific	71		64		80		86		64
Greater Asia/Africa	104		119		111		91		157
Total Oral, Personal and Home Care	455		431		386		344		375
Pet Nutrition	37		32		81		156		224
Corporate	73		74		83		75		85
Total Capital expenditures	$	565	$	537	$	550	$	575	$	684

	Years ended December 31,
	2012		2011		2010		2009		2008
Depreciation and amortization
Oral, Personal and Home Care
North America	$	50	$	56	$	56	$	59	$	54
Latin America	91		92		85		77		88
Europe/South Pacific	85		82		67		67		70
Greater Asia/Africa	81		79		69		63		61
Total Oral, Personal and Home Care	307		309		277		266		273
Pet Nutrition	50		51		45		36		32
Corporate	68		61		54		49		43
Total Depreciation and amortization	$	425	$	421	$	376	$	351	$	348

EXHIBIT 99.2

Colgate-Palmolive Company

Segment Information (Reclassified)

(Dollars in Millions) (Unaudited)

	At December 31,
	2012		2011		2010		2009		2008
Identifiable assets
Oral, Personal and Home Care
North America	$	2,157	$	2,247	$	2,196	$	2,237	$	1,955
Latin America	4,288		3,677		3,127		3,312		2,592
Europe/South Pacific	3,649		3,555		2,775		2,647		2,620
Greater Asia/Africa	2,169		2,069		1,943		1,760		1,704
Total Oral, Personal and Home Care	12,263		11,548		10,041		9,956		8,871
Pet Nutrition	1,045		1,078		1,081		1,127		1,025
Corporate(3)	86		98		50		51		83
Total Identifiable assets(4)	$	13,394	$	12,724	$	11,172	$	11,134	$	9,979

⁽³⁾  In 2012, Corporate identifiable assets primarily consist of derivative instruments (67%) and investments in equity securities (28%). In 2011, Corporate identifiable assets primarily consist of derivative instruments (73%) and investments in equity securities (22%). In 2010, Corporate identifiable assets primarily consist of derivative instruments (44%) and investments in equity securities (48%). In 2009, Corporate identifiable assets primarily consist of derivative instruments (44%) and investments in equity securities (46%). In 2008, Corporate identifiable assets primarily consist of derivative instruments (66%) and investments in equity securities (27%).

⁽⁴⁾  Long-lived assets in the U.S., primarily property, plant and equipment and goodwill and other intangibles represented approximately one-third of total long-lived assets of $8,066, $7,926, $7,116, $6,795 and $6,182 in 2012, 2011, 2010, 2009 and 2008, respectively.